Martina Midolo
Overview
Explore the profile of Martina Midolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dima F, Barison E, Midolo M, Benedetti F, Lippi G
Blood Transfus
. 2019 Aug;
18(1):67-76.
PMID: 31403932
Background: Successful peripheral blood stem cell (PBSC) collection depends on optimal timing of apheresis, as usually determined by flow cytometry CD34-positive () cell count in peripheral blood (PB). Since this...
2.
Takam Kamga P, Dal Collo G, Midolo M, Adamo A, Delfino P, Mercuri A, et al.
Cancer Res
. 2018 Dec;
79(3):639-649.
PMID: 30563887
Notch3 and Notch4 support survival of primary B-cell acute lymphoblastic leukemia (B-ALL) cells, suggesting a role for Notch signaling in drug response. Here we used , and mouse xenograft model-based...
3.
Takam Kamga P, Dal Collo G, Bassi G, Midolo M, Delledonne M, Chilosi M, et al.
Oncotarget
. 2018 May;
9(26):18341-18350.
PMID: 29719609
Notch signaling contribution to B-cell acute lymphoblastic leukemia (B-ALL) development is still under investigation. The serendipitous onset of B-ALL in a patient affected by the germinal Notch mutation-dependent Alagille syndrome...
4.
Di Trapani M, Bassi G, Midolo M, Gatti A, Takam Kamga P, Cassaro A, et al.
Sci Rep
. 2016 Apr;
6:24120.
PMID: 27071676
Mesenchymal stromal cells (MSCs) are multipotent cells, immunomodulatory stem cells that are currently used for regenerative medicine and treatment of a number of inflammatory diseases, thanks to their ability to...
5.
Takam Kamga P, Bassi G, Cassaro A, Midolo M, Di Trapani M, Gatti A, et al.
Oncotarget
. 2016 Mar;
7(16):21713-27.
PMID: 26967055
Both preclinical and clinical investigations suggest that Notch signalling is critical for the development of many cancers and for their response to chemotherapy. We previously showed that Notch inhibition abrogates...